[
  {
    "uuid": "9860619abd4826538c8053217629a1850dfba1e0",
    "url": "https://www.courier-journal.com/story/weather/2024/10/11/auroras-kentucky-northern-lights-2024-nasa-coronal-mass-ejections/75625230007",
    "ord_in_thread": 0,
    "parent_url": null,
    "author": ", The Courier-Journal",
    "published": "2024-10-11T13:24:00Z",
    "title": "Were you able to see the northern lights in Kentucky? These people did",
    "text": "Were you able to see the northern lights in Kentucky? These people did Ana RocÃ­o Ãlvarez BrÃ­Ã±ez , John Tufts Louisville Courier Journal People around the country, including in Kentucky, were able to see the northern lights on Thursday evening with some viewers capturing images of them and posting them to social media.\nA social media user named Neil Javins posted pictures on X, formerly Twitter, and said the northern lights were \"Absolutely unbelievable to witness.\"\nHere's what you need to know:\nWere the northern lights visible in Kentucky? Sometimes pictures do more justice than with the naked eye. The #NorthernLights are an example of that! All of these shots coming in along the #OhioValley last night. pic.twitter.com/UsHi0LKPEK\nâ€” Sam Gabrielli (@SamGabrielliwx) October 11, 2024 Absolutely unbelievable to witness #Aurora #northernlights #kentucky #kywx pic.twitter.com/c11sdPbGJp\nâ€” Neil Javins (@njavins) October 11, 2024 Just took a quick field trip to Oldham County (Brownsboro, KY). Even with activity slowly falling off a bit itâ€™s still good with night mode on a phone camera! #aurora #northernlights pic.twitter.com/egC3eQsKno\nâ€” Ryan Hoke âš¡ï¸ (@RyanHokeWAVE3) October 11, 2024 OMG! My mom spotted the Northern Lights while catering at @castleandkey Distillery in #Frankfort ! âœ¨ Can you see them from where you are? #northernlights pic.twitter.com/aKVcWJFtUL\nâ€” Madeline Carter (@WLKYMadeline) October 11, 2024 #northernlights Louisville, KY ðŸ¤© pic.twitter.com/UtUbkTFlSV\nâ€” Julie Dolan (@JulieDolanTV) October 11, 2024 Northern Lights Louisville Ky. 1st time seeing. The camera picked up a lot better than I could see. #northernlights pic.twitter.com/ILnJwF11sP\nâ€” Steven L (@SamLjacson1) October 11, 2024 Northern Lightsâ€¦..so cool #northernlights â¦ @MarcWeinbergWX â© pic.twitter.com/Fe0W2T18lz\nâ€” Allison Hayden Marshall (@allisonhm90) October 11, 2024 Such an awesome thing to see #northernlights pic.twitter.com/nlT4PqGgjE\nâ€” EdUcAtOR(EMK) (@ehandle77) October 11, 2024 #Kentucky #Campbellsburg #NorthernLights pic.twitter.com/0rqrURyAfx\nâ€” Tyler B (@T_Bloyd) October 11, 2024 Does this count? Our light pollution is so bad at our house but it kinda looks purple? #northernlights #Auroraborealis pic.twitter.com/XY611PhQV7\nâ€” Susanna Johnson (@Sunathetuna) October 11, 2024 I couldnâ€™t get away from the light pollution so this was my first ever view of the northern lights off our back deckâ€¦maybe @JimSichko will tell me his viewing spot for next time #northernlights pic.twitter.com/p21GitOBl0\nâ€” Patricia Watts (@PatriciaLWatts) October 11, 2024 Will I see auroras tonight in Louisville? Kentucky is outside the viewing line for auroras appearing Friday night, Oct. 11, according to NOAA.\nNational Weather Service of Louisville meteorologist Brian Schoettmer said the severe geomagnetic storm is at a G-3, which is categorized as a quiet aurora, according to NOAAâ€™s Space Weather Prediction Center (SWPC).\nSchoettmer said there is a chance people in Southern Indiana and Central Kentucky might see the auroras on Friday, but the chances are not as likely as they were on Thursday evening. He said the forecast calls for clear skies which can help with viewing.\nWhat is a severe geomagnetic storm? During a solar storm, an explosion of particles, energy, radiation and other matter can be blasted like a shotgun toward Earth by a solar flare. This material, called a coronal mass ejection (CME) can take 3-5 days to reach our planet, according to NASA . When it does, the CME can interfere with Earth's magnetic field, creating what experts call a geomagnetic storm.\nThese storms, depending on their strength, can interfere with radio waves and cause power outages. But they also produce beautiful auroras as Earth's magnetic field and atmosphere shields us from the worst of the geomagnetic storm.\nTips for viewing the northern lights Experts say the best auroras are usually within an hour or two of midnight (between 10 p.m. and 2 a.m. local time). These hours expand towards evening and morning as the level of geomagnetic activity increases. There may be aurora in the evening and morning, but it is usually not as active and therefore, not as visually appealing, according to NOAA.\nFacebook\nTwitter\nEmail",
    "highlightText": "",
    "highlightTitle": "",
    "highlightThreadTitle": "",
    "language": "english",
    "sentiment": "positive",
    "categories": [
      "Weather",
      "Human Interest",
      "Lifestyle and Leisure"
    ],
    "ai_allow": true,
    "webz_reporter": false,
    "external_links": [
      "https://science.nasa.gov/sun/solar-storms-and-flares/",
      "https://www.swpc.noaa.gov/",
      "https://swpc.noaa.gov/",
      "https://www.swpc.noaa.gov",
      "https://science.nasa.gov/sun/solar-storms-and-flares",
      "https://www.science.nasa.gov/sun/solar-storms-and-flares/"
    ],
    "external_images": [],
    "entities": {
      "persons": [
        {
          "name": "Brian Schoettmer",
          "sentiment": "none"
        },
        {
          "name": "Neil Javins",
          "sentiment": "none"
        }
      ],
      "organizations": [
        {
          "name": "National Weather Service",
          "sentiment": "none"
        },
        {
          "name": "NOAA",
          "sentiment": "none"
        }
      ],
      "locations": []
    },
    "syndication": {
      "syndicated": false,
      "syndicate_id": null,
      "first_syndicated": false
    },
    "rating": null,
    "crawled": "2024-10-11T17:32:50.662+03:00",
    "updated": "2024-10-11T20:47:12.706+03:00"
  },
  {
    "uuid": "88d2d15ab4064000d3834305fc9125e7c6521432",
    "url": "https://kdhnews.com/news/texas/local-nonprofits-gear-up-to-help-people-experiencing-homelessness-during-wintry-weather/article_1f5e94c9-c496-56b1-96ae-f5f059bd8232.html",
    "ord_in_thread": 0,
    "parent_url": null,
    "author": "Raquel Villatoro rvillatoro@tylerpaper.com",
    "published": "2024-01-12T21:00:00Z",
    "title": "Local nonprofits gear up to help people experiencing homelessness during wintry weather",
    "text": "Tyler resident Lillie Walton came by The Salvation Army in Tyler on Tuesday afternoon to donate blankets and socks she and her church collected.\nâ€œWe were just wanting to reach out and help,â€ said Walton, who is a member at Liberty Baptist Church.\nWalton is a former city government worker and enjoys finding ways to give back. She led the efforts for her church to organize and collect donations. Among the donations, there were four full-size blankets, 12 fleece throws, eight pairs of ladies socks, nine pairs of menâ€™s socks and two extra-large menâ€™s underwear.\nâ€œI know the help is needed and this time of year itâ€™s really needed,â€ Walton emphasized. â€œWe have more homeless people than I even realized. Since Iâ€™ve retired, Iâ€™ve just been kind of looking around, when I drive around in this areaâ€¦ but Iâ€™ve never seen so many homeless people as [there are] now.â€\nThe population of people experiencing homelessness in Smith County has increased, according to the latest statistics. In 2023, there were 328 people experiencing homelessness, according to the 2023 Point-in-Time Count Report for Smith County. This is an increase from 2022, when the number was 262. In Gregg County, there were 150 people experiencing homelessness in 2023, according to the 2023 PIT Count.\nThe PIT count is a count of sheltered and unsheltered people experiencing homelessness on a single night in January. The 2024 count is coming up this month.\nâ€œIn Tyler, in general, and even in Longview â€¦ weâ€™ve seen an influx of the homeless population compared to last year from different age groups as well,â€ said Jason Brandon, Director of Tyler Ministries at\nHiway 80 Rescue Mission. â€Unfortunately the homeless population is not going away.â€\nLocal organizations depend on the generosity of people like Walton. In the winter, PATH (People Attempting to Help) and The Salvation Army in Tyler both collect blankets to give to people who need them. PATH had fewer blankets in reserves this year, so the local nonprofit is in need of donations to distribute blankets to those in need. It also accepts monetary donations so it can purchase blankets through a supplier at a cheaper cost, according to PATH Executive Director Andrea Wilson-Lobaugh.\nSalvation Army in Tyler to open inclement weather shelter, warming station\nThe Salvation Army needs more adult blankets, said Trevesia Chevis, manager of social services at Salvation Army. Gateway to Hope in Tyler, part of Hiway 80 Rescue Mission, has jackets, gloves and scarves for people who come in. They are also a\nwarming station.\nAs\nwintry weather approaches next week, the Salvation Army has opened as a shelter for those who need to escape the cold. They have cots with blankets and pillows. In the social services building, one room can fit about 20 cots, in another room they can fit 4 to 5 cots. In the Womenâ€™s and Childrenâ€™s Auxiliary, they can fit 200. Women are kept upstairs separate from the men. During regular winter months, they also are a warming station during their office hours. The foyer has seating where people can warm up and drink water. They also have jackets and gloves they can provide.\nâ€œOur staff is always ready because we are an emergency shelter, we have to be prepared and what goes with that for the inclement weather is that we make sure that we do have the cots ready, blankets and extra pillows and things like that,â€ Chevis said. â€œ[We] make sure that we tell the kitchen to increase the meals because we also feed the community.â€\nThe Salvation Army requires photo IDs for anyone coming into their facilities. They also do a background check and those with sexual offenses on their records cannot come in. However once temperatures go below 10s, they do it on a case-by-case basis, according to Chevis.\nAt PATH, people come in to seek resources during winter months as electricity bills increase. They offer utilities assistance. In order to help residents, PATH needs a letter saying service will be disconnected. PATH can help a family once per year. In addition they give out blankets, one per family per year and once for year for anyone who is homeless. They use donations and funds dedicated to blankets to buy blankets which allows them to buy it at a cheaper rate. One employee tested the quality of blankets to make sure they would maintain heat without electricity, according to Wilson-Lobaugh.\nMany of the people coming in during winter months are people who are struggling. During the day they get elderly people who are on a fixed income. Later in the day, they will notice mothers with their kids who came after school. They also notice an increase in people visiting the food pantry, Wilson-Lobaugh said.\nâ€œWe have so many families who are living paycheck to paycheck just to make ends meet and that they have an unexpected expense of $150 because they get to replace a tire in their car back and forth to work,â€ Wilson-Lobaugh said. â€œThatâ€™s the difference from being able to pay the rent. Because thatâ€™s how close they are. They donâ€™t have the luxury of putting money back into sight.â€\nThe Tyler Street Team works hands on with the homeless community. On Saturdays, they are at Church Under the Bridge, organized by Hunger for Love. In addition Tyler Street Team hands out beanies, hand warmers and socks. They also help people through their hotline (903-253-0301) and place people in hotels. They have two or three zero-rated sleeping bags and three or four heated vests so those who have nowhere to go can stay warm, Tyler Street Team Executive Director Shana Yeatts said.\nThrough their work on the ground, Tyler Street Team volunteers know who the people are who need these items.\nPATH will be closed on Monday for Martin Luther King Jr. Day. However Gateway to Hope will be open 8 a.m. to 4 p.m. on Monday. They will resume their normal hours, Monday through Friday from 8 a.m. to 8 p.m. on Tuesday. In addition to being a warming center, Gateway to Hope helps those experiencing homelessness by offering snacks, providing a place to shower and a place to do laundry.\nSmith County, City of Tyler weather response plan guides public on preparedness as winter weather approaches\nâ€œWe canâ€™t do what we do without the help of our community and we definitely want the homeless safe during this weather and weâ€™re committed to do what we can to help them,â€ Brandon said. â€œIf anyone finds themselves on the street or homeless or without adequate heating during the threat of snow and ice, they can find themselves at Gateway and we can help them the best we can.â€\nNWS warns of wintry mix in East Texas; freezing rain, sleet expected City of Tyler monitoring winter weather conditions Ciudad de Tyler monitorea las condiciones de tiempo invernal",
    "highlightText": "",
    "highlightTitle": "",
    "highlightThreadTitle": "",
    "language": "english",
    "sentiment": "positive",
    "categories": [
      "Human Interest",
      "Weather",
      "Social Issue"
    ],
    "external_links": [
      "https://hiway80rm.org",
      "https://www.hiway80rm.org"
    ],
    "external_images": [],
    "entities": {
      "persons": [
        {
          "name": "lillie walton",
          "sentiment": "negative"
        },
        {
          "name": "tyler",
          "sentiment": "negative"
        },
        {
          "name": "walton",
          "sentiment": "none"
        }
      ],
      "organizations": [
        {
          "name": "salvation army",
          "sentiment": "negative"
        },
        {
          "name": "liberty baptist church",
          "sentiment": "none"
        },
        {
          "name": "time count report for smith co",
          "sentiment": "none"
        }
      ],
      "locations": [
        {
          "name": "smith county",
          "sentiment": "none"
        }
      ]
    },
    "rating": null,
    "crawled": "2024-01-12T23:35:06.939+02:00",
    "updated": "2024-01-12T23:35:06.939+02:00"
  },
  {
    "uuid": "85f976b6a203e7d83d3e0fc14ca13496c607e825",
    "url": "https://www.tudn.com/nfl/cleveland-browns-clasifica-nfl-playoffs-vencer-new-york-jets",
    "ord_in_thread": 0,
    "parent_url": null,
    "author": "@TUDNUSA",
    "published": "2023-12-29T05:22:00Z",
    "title": "Cleveland Browns clasifica a los NFL Playoffs al vencer a New York Jets | TUDN NFL | TUDN",
    "text": "[NFL](/temas/nfl) Cleveland Browns clasifica a NFL Playoffs al vencer a New York Jets Browns asegurÃ³ un lugar en la Ronda de Comodines de la postemporada gracias a un inspirado Joe Flacco. Cleveland Browns [clasificÃ³ a NFL Playoffs](https://www.tudn.com/nfl/asi-se-juegan-playoffs-nfl-2023-momento-rumbo-super-bowl-lviii) al vencer este jueves a 37-20 a New York Jets en el inicio de la Semana 17 de la NFL. Browns regresa a una postemporada tres aÃ±os despuÃ©s de la Ãºltima vez que avanzaron en 2020 y por tercera vez desde el 2000, la otra ocasiÃ³n fue en el 2022. Joe Flacco nuevamente tuvo un gran partido en el emparrillado con mÃ¡s de 300 yardas por aire, tres pases de touchdowns y solo una intercepciÃ³n. El experimentado quarterback encontrÃ³ en par de ocasiones en las diagonales a Jerome Ford y una vez a Elijah Moore. Browns se fue al descanso con 34 puntos en la bolsa, gracias a otra anotaciÃ³n de Kareem Hunt en la vÃ­a terrestre. Tan solo en el primer cuarto Cleveland iba arriba 20-7 y en el segundo cuarto aumentÃ³ la ventaja con un parcial de 14-10 sobre Jets, que se mantuvo en el juego gracias a su defensiva. New York con Trevor Siemian en los controles, lanzÃ³ 242 yardas con un touchdown y una intercepciÃ³n. El corredo Breece Hall tuvo 84 yardas por tierra y aÃ±adiÃ³ 42 por aire con una anotaciÃ³n. El tercer cuarto no tuvo puntos para ninguno de los dos equipos y el cuarto periodo estuvo en un intercambio de posesiones gracias al buen trabajo de las defensivas que las ofensivas no pudieron aprovechar.",
    "highlightText": "",
    "highlightTitle": "",
    "highlightThreadTitle": "",
    "language": "spanish",
    "sentiment": "positive",
    "categories": [
      "Sport",
      "Human Interest",
      "War, Conflict and Unrest"
    ],
    "external_links": [],
    "external_images": [],
    "entities": {
      "persons": [],
      "organizations": [],
      "locations": []
    },
    "rating": null,
    "crawled": "2023-12-29T11:38:15.776+02:00",
    "updated": "2023-12-29T11:38:15.776+02:00"
  },
  {
    "uuid": "f778c50ee4c9c83a5e9abb17bfe7dd2998e801cf",
    "url": "https://www.dvidshub.net/image/8493216/nws-yorktown-recognizes-sailors-and-civilians-who-served-part-incident-management-team-during-hurrex-cg2024",
    "ord_in_thread": 0,
    "parent_url": null,
    "author": "Max Lonzanida",
    "published": "2024-06-24T04:07:00Z",
    "title": "NWS Yorktown recognizes Sailors and Civilians who served as part of the Incident Management Team during HURREX-CG2024 [Image 4 of 12]",
    "text": "Yorktown, Va. (June 21, 2024) Captain Dan Patrick, Commanding Officer, Naval Weapons Station Yorktown presents a letter of recognition to PSC Johanna James who served as part of the installationâ€™s Incident Management Team (IMT) during exercise HURREX-CG2024 earlier this year. Hurricane Exercise (HURREX) and Citadel Gale (CG) are annual exercises conducted in mid-spring in preparation for the Atlantic hurricane season. The exercises provide focused hurricane preparation, recovery, consequence management and personnel account procedures training for afloat and shore-based East Coast and Gulf Coast commands. The exercises also focus on installation response and recovery to hurricane preparation, hurricane recovery and Navy family support. (U.S. Navy Photo by Max Lonzanda/Released).\n|Date Taken:||06.21.2024|\n|Date Posted:||06.24.2024 00:07|\n|Photo ID:||8493216|\n|VIRIN:||240621-N-TG517-6708|\n|Resolution:||3470x2556|\n|Size:||1.6 MB|\n|Location:||YORKTOWN, VIRGINIA, US|\n|Web Views:||1|\n|Downloads:||0|\nThis work, NWS Yorktown recognizes Sailors and Civilians who served as part of the Incident Management Team during HURREX-CG2024 [Image 12 of 12], by\n[Max Lonzanida](/portfolio/1518123/max-lonzanida), identified by DVIDS, must comply with the restrictions shown on https://www.dvidshub.net/about/copyright.",
    "highlightText": "",
    "highlightTitle": "",
    "highlightThreadTitle": "",
    "language": "english",
    "sentiment": "positive",
    "categories": [
      "Human Interest",
      "Disaster and Accident"
    ],
    "webz_reporter": false,
    "external_links": [],
    "external_images": [],
    "entities": {
      "persons": [
        {
          "name": "dan patrick",
          "sentiment": "neutral"
        },
        {
          "name": "johanna james",
          "sentiment": "none"
        },
        {
          "name": "max lonzanda",
          "sentiment": "none"
        }
      ],
      "organizations": [
        {
          "name": "nws yorktown",
          "sentiment": "neutral"
        },
        {
          "name": "citadel gale",
          "sentiment": "none"
        },
        {
          "name": "gulf coast",
          "sentiment": "none"
        },
        {
          "name": "psc",
          "sentiment": "none"
        },
        {
          "name": "navy",
          "sentiment": "none"
        },
        {
          "name": "u.s. navy",
          "sentiment": "none"
        }
      ],
      "locations": [
        {
          "name": "va.",
          "sentiment": "none"
        },
        {
          "name": "east coast",
          "sentiment": "none"
        },
        {
          "name": "virginia",
          "sentiment": "none"
        },
        {
          "name": "yorktown",
          "sentiment": "none"
        },
        {
          "name": "atlantic",
          "sentiment": "none"
        },
        {
          "name": "us",
          "sentiment": "none"
        }
      ]
    },
    "rating": null,
    "crawled": "2024-06-24T07:30:07.911+03:00",
    "updated": "2024-06-24T07:30:07.911+03:00"
  },
  {
    "uuid": "c1a32f9511cf720b99786d5e80b72d3ca45db1e4",
    "url": "https://money.mymotherlode.com/clarkebroadcasting.mymotherlode/article/gnwcq-2023-12-28-zoomcar-the-worlds-largest-emerging-market-focused-car-sharing-platform-announces-completion-of-its-business-combination-with-innovative-international-acquisition-corporation-ioac-and-anticipated-nasdaq-listing",
    "ord_in_thread": 0,
    "parent_url": null,
    "author": "Zoomcar Holdings, Inc. via GlobeNewswire",
    "published": "2023-12-28T22:17:00Z",
    "title": "Zoomcar, the Worldâ€™s Largest Emerging Market Focused Car Sharing Platform, Announces Completion of its Business Combination with Innovative International Acquisition Corporation (IOAC) and Anticipated Nasdaq Listing",
    "text": "Recent Quotes View Full List My Watchlist Create Watchlist Indicators Industrial Estimate Composite Estimate 500 Stocks Estimate Gold Crude Oil Markets Stocks ETFs Tools Overview News Currencies International Treasuries Zoomcar, the Worldâ€™s Largest Emerging Market Focused Car Sharing Platform, Announces Completion of its Business Combination with Innovative International Acquisition Corporation (IOAC) and Anticipated Nasdaq Listing By: Zoomcar Holdings, Inc. via GlobeNewswire December 28, 2023 at 17:17 PM EST Zoomcar, Inc. and IOAC consummated the merger transaction comprising IOACâ€™s initial business combination on December 28, 2023 Combined Company will be named Zoomcar Holdings, Inc. expects to begin trading on NASDAQ under ticker symbol â€œZCARâ€ stock ticker on December 29, 2023 Zoomcar is a leading emerging market peer2peer car sharing platform with operations across India, Indonesia and Egypt Zoomcar and IOAC entered into a definitive merger agreement dated October 13, 2022 (the \"Merger Agreement\") Bangalore, India and New York, NY, Dec. 28, 2023 (GLOBE NEWSWIRE) -- Innovative International Acquisition Corporation (NASDAQ: IOAC, or â€œIOACâ€), formerly a Cayman Island registered blank-check special purpose acquisition company, and Zoomcar, Inc. (â€œZoomcarâ€), an emerging market focused peer2peer car sharing company, are pleased to announce the closing (â€œClosingâ€) of their previously announced merger (the â€œBusiness Combinationâ€). Prior to Closing, IOAC transferred by way of continuation out of the Cayman Islands and into the State of Delaware, so as to become a Delaware corporation.\nThe Combined Company resulting from the merger was, effective at Closing, renamed Zoomcar Holdings, Inc. (â€œZoomcar Holdingsâ€) and expects to begin trading on NASDAQ on December 29, 2023 under the ticker symbol â€œZCARâ€ for its common stock and â€œZCARWâ€ for its publicly traded warrants.\nIOACâ€™s shareholders approved the Business Combination, among other related matters, at an extraordinary general meeting held on December 19, 2023. The Business Combination, among other related matters, was also approved by Zoomcar stockholders, including certain holders of shares of Zoomcar India Private Limited, a wholly owned Zoomcar subsidiary.\nGreg Moran, CEO and Co-Founder of Zoomcar commented, â€œWeâ€™re thrilled to announce this exciting milestone in Zoomcarâ€™s nearly decade long company journey. This marks the beginning of an important new phase in our companyâ€™s growth as we embark on reaching new heights for our emerging market focused peer2peer car sharing platform. We thank the IOAC team for partnering with us in these efforts.â€\nMohan Ananda, Chairman and CEO of IOAC, who has also been approved by IOAC shareholders as nominee to the board of directors of Zoomcar Holdings and is expected to serve as the initial Chairman of the Zoomcar Holdings board, expressed his joy regarding the successful conclusion of Innovativeâ€™s business combination with Zoomcar, â€œAs an innovative peer-to-peer car-sharing company, Zoomcar holds immense potential to establish a global community of car owners and renters. With Zoomcar's exceptional management team, we are poised to make a transformative impact on traditional industries. Our collaborative efforts aim to challenge norms, create opportunities for active participation in the sharing economy, and redefine the future of mobility on a global scale.\"\nWith the closing of the merger, IOAC has been renamed Zoomcar Holdings, Inc., and will continue to operate under the Zoomcar management team, led by Greg Moran, Zoomcar, Inc.â€™s Co-Founder and Chief Executive Officer. Shares of Zoomcar common stock are expected to begin trading under the symbol ZCAR on the Nasdaq Global Market platform on or about December 29, 2023; publicly trading warrants are expected to be listed on the Nasdaq Capital Market platform on or about the same date.\nAdvisors\nCohen & Company Capital Markets, a division of J.V.B. Financial Group, LLC, acted as exclusive financial advisor and exclusive capital markets advisor to Zoomcar; DLA Piper LLP (US) acted as legal advisor to Cohen & Company Capital Markets. Ellenoff Grossman & Schole LLP acted as US legal advisor to Zoomcar. Lincoln International acted as financial advisor to the special committee of the board of directors of Innovative (the â€œSpecial Committeeâ€). Morris, Nichols, Arsht & Tunnell LLP acted as legal advisor to the Special Committee. McDermott Will & Emery LLP acted as US legal advisor to Innovative. Weinberg Zareh Malkin Price LLP acted as US legal advisor to Ananda Small Business Trust.\nAbout Zoomcar\nFounded in 2013 and headquartered in Bengaluru, India, Zoomcar is a leading marketplace for car sharing focused on emerging markets. The Zoomcar community connects hosts with guests, who choose from a selection of cars for use at affordable prices, promoting sustainable, smart transportation solutions in growing markets.\nForward-Looking Statements\nThis press release contains â€œforward-looking statementsâ€ within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements include, but are not limited to, statements about future financial and operating results, our plans, objectives, expectations and intentions with respect to future operations, products and services; and other statements identified by words such as â€œwill likely result,â€ â€œare expected to,â€ â€œwill continue,â€ â€œis anticipated,â€ â€œestimated,â€ â€œbelieve,â€ â€œintend,â€ â€œplan,â€ â€œprojection,â€ â€œoutlookâ€ or words of similar meaning.\nThese forward-looking statements and factors that may cause actual results and the timing of events to differ materially from the anticipated results include, but are not limited to: (1) the risk that the Business Combination disrupts current plans and operations of Zoomcar as a result of the announcement and consummation of the Business Combination; (2) the ability to recognize the anticipated benefits of the Business Combination, which may be affected by, among other things, competition, the ability of Zoomcar to grow and manage growth profitably, maintain its reputation, grow its customer base, maintain relationships with customers and suppliers and retain its management and key employees; (3) the impact of the COVID-19 pandemic on the business of Zoomcar (including the effects of the ongoing global supply chain shortage); (4) Zoomcarâ€™s limited operating history and history of net losses and Zoomcarâ€™s incurrence of additional significant liabilities and expenses in connection with the Business Combination, resulting in an expectation that the post-Closing company will pursue opportunities to raise capital in the near and intermediate term after the Business Combination; (5) Zoomcarâ€™s customer concentration and reliance on a limited number of key technology providers and payment processors facilitating payments to and by Zoomcarâ€™s customers; (6) costs related to the Business Combination; (7) unfavorable interpretations of laws or regulations or changes in applicable laws or regulations; (8) the possibility that Zoomcar may be adversely affected by other economic, business, regulatory, and/or competitive factors; (9) Zoomcarâ€™s estimates of expenses and profitability; (10) the evolution of the markets in which Zoomcar competes; (11) political instability associated with operating in current and future emerging markets Zoomcar has entered or may later enter; (12) risks associated with Zoomcar maintaining inadequate insurance to cover risks associated with business operations now or in the future; (13) the ability of Zoomcar to implement its strategic initiatives and continue to innovate its existing products; (14) the ability of Zoomcar to adhere to legal requirements with respect to the protection of personal data and privacy laws; (15) cybersecurity risks, data loss and other breaches of Zoomcarâ€™s network security and the disclosure of personal information or the infringement upon Zoomcarâ€™s intellectual property by unauthorized third parties; (16) risks associated with the performance or reliability of infrastructure upon which Zoomcar relies, including, but not limited to, internet and cellular phone services; (17) the risk of regulatory lawsuits or proceedings relating to Zoomcarâ€™s products or services; (18) increased compliance risks associated with operating in multiple foreign jurisdictions at once, including regulatory and accounting compliance issues; (19) Zoomcarâ€™s exposure to operations in emerging markets where improper business practices may be prevalent; (20) Zoomcarâ€™s ability to obtain additional capital when necessary; (21) the risk that Zoomcarâ€™s significant increased expenses and administrative burdens as a public company could have an adverse effect on its business, financial condition and results of operations; (22) if the benefits of the Business Combination do not meet the expectations of investors or securities analysts, the potential for the market price of Zoomcarâ€™s securities to decline; (23) the ability to obtain or maintain the listing of common stock or warrants on Nasdaq following the Business Combination; (24) Zoomcarâ€™s management teamâ€™s limited experience managing a public company; and (25) other risks and uncertainties identified in the Registration Statement (No. 333-269627), initially filed with the Securities and Exchange Commission (the â€œSECâ€) on February 7, 2023, as amended and supplemented, relating to the Business Combination, including those under â€œRisk Factorsâ€ therein, and in other filings with the SEC made by Innovative, Zoomcar, or New Zoomcar.\nThe foregoing list of factors is not exhaustive. You should carefully consider the foregoing factors and the other risks and uncertainties described in the â€œRisk Factorsâ€ section of the registration statement referenced above and other documents filed by Zoomcar from time to time with the SEC. These filings identify and address other important risks and uncertainties that could cause actual events and results to differ materially from those contained in the forward-looking statements. There can be no assurance that the data contained herein is reflective of future performance to any degree. You are cautioned not to place undue reliance on forward-looking statements as a predictor of future performance as projected financial information and other information are based on estimates and assumptions that are inherently subject to various significant risks, uncertainties and other factors, many of which are beyond our control. Forwardâ€‘looking statements speak only as of the date they are made, and the combined com disclaim any intention or obligation to update or revise any forward-looking statements, whether as a result of developments occurring after the date of this communication. Forecasts and estimates regarding Zoomcarâ€™s industry and end markets are based on sources we believe to be reliable, however there can be no assurance these forecasts and estimates will prove accurate in whole or in part. Annualized, pro forma, projected and estimated numbers are used for illustrative purpose only, are not forecasts and may not reflect actual results.\nMedia:\nSurabi Shetty, PR Lead\nsurabi.shetty@zoomcar.com\nZoomcar, Inc.\nGreg Moran, CEO & Co-Founder\nGreg@zoomcar.com",
    "highlightText": "",
    "highlightTitle": "",
    "highlightThreadTitle": "",
    "language": "english",
    "sentiment": "positive",
    "categories": [
      "Science and Technology",
      "Economy, Business and Finance",
      "Health"
    ],
    "external_links": [
      "https://www.globenewswire.com/Tracker?data=eMmiubT_5yzi7plFEltszVQvhLj0vP9gy69Q9lPkpgx6uS9vLNPB0h9-vvh2-dp68VoqC9K5fqLuyfbM0bUFXumPb0lKlgzS6kJRT0Xko4A=",
      "https://fonts.googleapis.com/css2?family=Open+Sans&display=swap",
      "https://www.globenewswire.com/Tracker?data=RztXgumTK2co2jRomqdfggB4S9yCR0q0BaiRVJDYl4B8SWhziRElV97-Z-cl2SkNk3kcSgqNeoeBX_lnFMwmyxIY8JGPJTapFhZPaLAteJ_i52tMdNfW3y5RYWdc4axm",
      "https://www.globenewswire.com/newsroom/ti?nf=OTAxMDQ0NiM1OTk3MzgzIzUwMDEyMTA4NA==",
      "https://www.globenewswire.com/styles/gnw_nitf.css",
      "https://fonts.googleapis.com/css2?family=Open+Sans+Condensed:wght@700&display=swap",
      "https://www.fonts.googleapis.com/css2?family=Open+Sans&display=swap",
      "https://www.fonts.googleapis.com/css2?family=Open+Sans+Condensed:wght@700&display=swap",
      "https://globenewswire.com/Tracker?data=eMmiubT_5yzi7plFEltszVQvhLj0vP9gy69Q9lPkpgx6uS9vLNPB0h9-vvh2-dp68VoqC9K5fqLuyfbM0bUFXumPb0lKlgzS6kJRT0Xko4A=",
      "https://www.globenewswire.com/newsroom/ti",
      "https://globenewswire.com/Tracker?data=RztXgumTK2co2jRomqdfggB4S9yCR0q0BaiRVJDYl4B8SWhziRElV97-Z-cl2SkNk3kcSgqNeoeBX_lnFMwmyxIY8JGPJTapFhZPaLAteJ_i52tMdNfW3y5RYWdc4axm",
      "https://globenewswire.com/newsroom/ti?nf=OTAxMDQ0NiM1OTk3MzgzIzUwMDEyMTA4NA==",
      "https://www.globenewswire.com/Tracker",
      "https://fonts.googleapis.com/css2",
      "https://globenewswire.com/styles/gnw_nitf.css"
    ],
    "external_images": [],
    "entities": {
      "persons": [
        {
          "name": "zoomcar",
          "sentiment": "neutral"
        }
      ],
      "organizations": [
        {
          "name": "innovative international acquisition corporation",
          "sentiment": "neutral"
        },
        {
          "name": "nasdaq",
          "sentiment": "none"
        },
        {
          "name": "zoomcar holdings, inc.",
          "sentiment": "none"
        },
        {
          "name": "zoomcar, inc.",
          "sentiment": "none"
        },
        {
          "name": "ioac",
          "sentiment": "none"
        }
      ],
      "locations": [
        {
          "name": "new york",
          "sentiment": "none"
        },
        {
          "name": "egypt zoomcar",
          "sentiment": "none"
        },
        {
          "name": "ny",
          "sentiment": "none"
        },
        {
          "name": "india",
          "sentiment": "none"
        },
        {
          "name": "indonesia",
          "sentiment": "none"
        },
        {
          "name": "bangalore",
          "sentiment": "none"
        }
      ]
    },
    "rating": null,
    "crawled": "2023-12-29T00:37:29.811+02:00",
    "updated": "2023-12-29T00:37:29.811+02:00"
  },
  {
    "uuid": "84398c7f9d8acfd2b4e95005213f9e9533db8ecf",
    "url": "https://www.sofoot.com/breves/le-portugal-demarre-bien-contre-la-croatie-lespagne-au-ralenti-en-serbie",
    "ord_in_thread": 0,
    "parent_url": null,
    "author": "@sofoot",
    "published": "2024-09-05T21:48:00Z",
    "title": "Le Portugal dÃ©marre bien contre la Croatie, lâ€™Espagne au ralenti en Serbie - Ligue des nations - RÃ©sumÃ© - SO FOOT.com",
    "text": "- Ligue des nations - RÃ©sumÃ© Le Portugal dÃ©marre bien contre la Croatie, lâ€™Espagne au ralenti en Serbie Et câ€™est reparti pour un tour ! Ce jeudi marquait le coup dâ€™envoi de la quatriÃ¨me Ã©dition de la Ligue des nations. Du cÃ´tÃ© de Lisbonne, le Portugal a su faire rapidement la diffÃ©rence pour prendre le meilleur sur une Croatie qui ne sâ€™avoue jamais vaincue. La SeleÃ§ao trouve rapidement la faille grÃ¢ce Ã  Diogo Dalot, parfaitement trouvÃ© dans la surface par Bruno Fernandes. Le break ne peut ensuite venir que de Cristiano Ronaldo, [qui continue dâ€™Ã©crire sa lÃ©gende](https://www.sofoot.com/breves/cristiano-ronaldo-inscrit-son-900e-but-en-carriere-lors-de-portugal-croatie), tandis que la remise de Borna Sosa dÃ©viÃ©e dans ses propres filets par Dalot reste sans consÃ©quences. Une victoire inaugurale qui place les Portugais en tÃªte de ce groupe 1, Ã  hauteur de la Pologne. Cette derniÃ¨re sâ€™est en effet imposÃ©e sur le fil en Ecosse grÃ¢ce Ã  un penalty de Nicola Zalewski, alors que la Tartan Army avait remontÃ© deux buts de retard en seconde pÃ©riode. ðŸ‡µðŸ‡¹ðŸ‡­ðŸ‡· Le 131e but de Cristiano Ronaldo avec le Portugal ! Suivez le match en direct sur la chaine L'Ã‰quipe > [https://t.co/pXI4SIbEoH] [#lequipeFOOT] [#PORCRO] [pic.twitter.com/S2TnxiGzKB] â€” la chaine L'Ã‰quipe (@lachainelequipe) [September 5, 2024] La soirÃ©e a Ã©tÃ© beaucoup moins animÃ©e dans le groupe 4, avec deux petits buts inscrits. Ils sont lâ€™Å“uvre du jeune Patrick Dorgu, 19 ans et attaquant danois Ã©voluant Ã  Lecce et du capitaine Pierre-Emile HÃ¸jbjerg. Il permettent surtout Ã  la Danish Dynamite de crÃ©er une petite surprise en dominant la Suisse Ã  Copenhague en fin de partie. Dans le mÃªme temps, les tenants du titre et champions dâ€™Europe espagnols nâ€™ont pas rÃ©ussi Ã  trouver la faille en Serbie. Dani Carvajal, Lamine Yamal ou Fabian Ruiz dâ€™un cÃ´tÃ© et Luka JoviÄ‡ de lâ€™autre se sont bien essayÃ©s, sans parvenir Ã  trouver la faille. Portugal 2-1 Croatie Buts : Dalot (7e) et C. Ronaldo (34e) pour la SeleÃ§ao // Dalot (41e, CSC) Ecosse 2-3 Pologne Buts : Gilmour (46e) et McTominay (76e) pour la Tartan Army // SzymaÅ„ski(8e), Lewandowski (44e, SP) et Zalewski (90e+7, SP) pour les BiaÅ‚o-czerwoni Serbie 0-0 Espagne Danemark 2-0 Suisse Buts : Dorgu (82e) et HÃ¸jbjerg (90e+2) Expulsions : Elvedi (52e) et Xhaka (87e) pour la Nati [Lâ€™Ã©quipe type de lâ€™Euro 2024](https://www.sofoot.com/articles/lequipe-type-de-leuro-2024) TB",
    "highlightText": "",
    "highlightTitle": "",
    "highlightThreadTitle": "",
    "language": "french",
    "sentiment": "positive",
    "categories": [
      "Sport"
    ],
    "ai_allow": true,
    "webz_reporter": false,
    "external_links": [],
    "external_images": [],
    "entities": {
      "persons": [],
      "organizations": [],
      "locations": []
    },
    "syndication": null,
    "rating": null,
    "crawled": "2024-09-06T00:58:16.817+03:00",
    "updated": "2024-09-06T00:58:16.817+03:00"
  },
  {
    "uuid": "79998459d05d363b60b26d225c4e5c450f31d377",
    "url": "https://www.openpr.com/news/4127329/innovative-drugs-market-expansion-driven-by-r-d-investments",
    "ord_in_thread": 0,
    "author": "Persistence Market Research",
    "published": "2025-07-31T04:35:32Z",
    "title": "Innovative Drugs Market Expansion Driven by R&D Investments -",
    "text": "Innovative Drugs Market Expansion Driven by R&D Investments - Persistence Market Research Analysis 07-31-2025 06:25 AM CET | Health & Medicine\nPress release from: Persistence Market Research Innovative Drugs Market\nThe innovative drugs market has emerged as a key driver in the global healthcare ecosystem, bringing forward novel solutions to patients afflicted with diseases that lack effective or satisfactory treatments. As scientific understanding and technologies evolve, the boundaries between once-incurable diseases and recovery are being steadily dissolved through the advent of these transformative pharmaceuticals. According to persistence market research, this sector stands at the forefront of medical advancement, addressing unmet needs in oncology, neurology, infectious diseases, and more. The dynamic interplay between research & development (R&D), regulatory landscapes, and rising global health awareness continues to reshape market fundamentals.\nâœ…Get a Sample Copy of Research Report (Use Corporate Mail id for Quick Response): https://www.persistencemarketresearch.com/samples/3311\nâœ… Overview of the Innovative Drugs Market\nThe innovative drugs market is characterized by the development, approval, and commercial distribution of novel medications designed to target specific pathologies where conventional therapies fall short. These drugs may either represent entirely new classes of therapeutics or significant improvements over existing molecules, offering better efficacy, safety, or convenience. Innovative drugs are utilized across a spectrum of complex diseases, including cancer, osteoarthritis, Alzheimer's disease, chronic obstructive pulmonary disorders (COPD), Parkinson's disease, and treatment-resistant infections.\nSeveral critical growth drivers underpin this market's momentum: a surge in R&D investments, accelerated pace of technological progress, rising disease burden, and the urgent global need for advanced treatment options. The need to improve on current drug outcomes, together with heightened concerns over morbidity and mortality rates in chronic and rare illnesses, is catalyzing both public and private stakeholders to innovate rapidly. North America stands out as the leading geographical region, propelled by a strong ecosystem of innovation, abundant capital, and supportive regulatory frameworks, while Asia is poised for rapid catch-up, fueled by demographic trends, outsourcing, and growing healthcare awareness.\nâœ… Key Highlights from the Report:\nâž¤ Innovative drugs provide novel therapeutic solutions for diseases where existing treatments are insufficient.\nâž¤ R&D intensity and technological advancement are the central engines of market growth.\nâž¤ Oncology remains the largest and fastest-expanding segment due to rising cancer incidence and ongoing drug pipeline activity.\nâž¤ North America leads the market share on account of robust R&D, advanced healthcare infrastructure, and large patient populations.\nâž¤ Stringent regulatory environments and escalating development costs present challenges to market entry and expansion.\nâž¤ Asia Pacific is witnessing the highest growth rate, buoyed by expanding healthcare infrastructure, rising disease prevalence, and increased investments in drug discovery.\nâœ… Market Segmentation\nThe innovative drugs market can be segmented by product type, therapeutic area, technology platform, and end-user, among other dimensions. On the product type front, segmentation typically occurs between small-molecule drugs and biologics-a class that includes monoclonal antibodies, gene therapies, and cell therapies. Biologics have witnessed faster growth in recent years, driven by advancements in biotechnology, personalized medicine, and targeted therapies that address complex, multifactorial diseases.\nTherapeutically, oncology dominates the landscape as the leading segment, fueled by a relentless increase in cancer incidence globally and continuous breakthroughs in molecular targeting and immunotherapies. Other key segments include neurology (covering ailments like Alzheimer's, Parkinson's, and epilepsy), infectious diseases (including antiviral, antibacterial, and antiparasitic agents), and chronic conditions such as diabetes and autoimmune disorders. End-users span from hospitals and specialty clinics to research institutions and retail pharmacies, each serving as vital conduits for drug delivery and patient care.\nâœ…Read Detailed Analysis: https://www.persistencemarketresearch.com/market-research/innovative-drugs-market.asp\nâœ… Regional Insights\nNorth America is the global leader in the innovative drugs market. This dominance is attributed to high rates of drug approval, broad access to advanced healthcare, and a mature regulatory environment encouraging both local and multinational biopharma giants. The region is further empowered by a concentration of leading academic centers, world-renowned research institutions, and a favorable reimbursement landscape that hastens market adoption.\nEurope follows closely, holding significant market share, thanks to its established infrastructure, high investment in research, and the presence of major pharmaceutical firms. The continent's regulatory rigor ensures patient safety and high-quality therapeutics but may increase the time and resources needed to bring new drugs to market.\nAsia Pacific, meanwhile, is experiencing a surge in market activity, with China, Japan, and India at the forefront. The region benefits from growing R&D investments, expanded outsourcing capabilities, and demographic shifts such as aging populations and rising chronic disease incidence. Government initiatives aiming to improve healthcare access and attract international pharma investments further strengthen Asia Pacific's outlook. The Middle East, Africa, and Latin America-grouped as Rest of World (RoW)-show robust potential but face challenges related to market access, intellectual property protection, and disparities in healthcare delivery.\nâœ… Market Drivers\nThe innovative drugs market is riding a wave of several reinforcing forces:\nRising Disease Burden: Chronic and rare diseases-cancer, neurodegeneration, and infectious outbreaks-are motivating intense research for more effective therapies where current options are limited.\nTechnological Advancements: The integration of artificial intelligence, genomics, and next-generation sequencing in drug discovery accelerates timeline from molecule to market and heightens precision in target identification.\nR&D Investment: Biopharma's increased willingness to allocate resources to early-phase development, strategic collaborations, and open innovation ecosystems has led to a richer drug pipeline and more blockbuster launches.\nPatient Demand for Personalization: Growing public awareness and education around health choices spurs demand for drugs tailored to individual genetic and environmental factors, moving healthcare from \"one-size-fits-all\" to customized interventions.\nRegulatory Support and Incentives: Accelerated approval pathways, orphan drug designations, and incentives for breakthrough therapies reduce time to market for drugs addressing unmet needs.\nâœ… Market Restraints\nDespite bright prospects, the innovative drugs market faces significant barriers:\nRegulatory Complexity: Obtaining regulatory approval is a resource-intensive, protracted process. Innovative drugs must prove superiority or significant improvement over current standards, often requiring extensive multi-phase clinical trials.\nHigh Development Costs: The investment required for successful drug discovery, clinical validation, and commercialization is enormous, deterring entry by smaller players and increasing pressure on return-on-investment.\nEconomic Volatility: Fluctuating currency rates, inflation, and reimbursement uncertainties can impact both the funding of R&D and subsequent patient access, especially in less-developed markets.\nIntellectual Property Risks: Patent protections are critical for recouping R&D investments but may be threatened in regions with weaker enforcement or compulsory licensing provisions.\nComplexity of Market Access: Variability in pricing, reimbursement, and formularies across geographies can delay or limit the reach of new therapies.\nâœ… Market Opportunities\nAmid the challenges, several transformative opportunities exist:\nEmerging Markets Expansion: Rapidly developing economies in Asia, Latin America, and Africa present untapped patient populations, lower operational costs, and opportunities for local partnerships and customization.\nCollaborative Innovation Models: Strategic alliances, co-development, and licensing arrangements allow sharing of cost, risk, and expertise-expediting timelines and improving success rates in drug discovery.\nAdvances in Biotechnology: The development of gene and cell therapies, RNA-based drugs, and digital therapeutics creates entirely new therapeutic classes and expands treatment frontiers.\nRegulatory Flexibility: Initiatives to harmonize regulatory processes, encourage real-world evidence, and expedite orphan and breakthrough drugs can foster quicker innovation cycles.\nHealthcare Digitization: Big data, telemedicine, and digital health ecosystems open new avenues for patient engagement, adherence monitoring, and data-driven decision-making, enhancing the overall value proposition for innovative drugs.\nâœ…Request for Customization of the Research Report: https://www.persistencemarketresearch.com/request-customization/3311\nâœ… Reasons to Buy the Report\nâœ” Delivers a comprehensive analysis of the innovative drugs market landscape, covering all key segments, emerging regions, and technology trends.\nâœ” Provides actionable insights into R&D and regulatory dynamics that influence successful drug development and commercialization strategies.\nâœ” Highlights the latest trends in mergers, acquisitions, and strategic collaborations driving future market growth.\nâœ” Equips decision-makers with in-depth competitor profiling and case studies of leading companies and pipeline drugs.\nâœ” Offers a forward-looking perspective on opportunities for investment, expansion, and technological partnerships across geographies.\nâœ… Company Insights\nâœ¦ Bio-Rad Laboratories\nâœ¦ Abbott Laboratories\nâœ¦ Stratasys 3D Printers\nâœ¦ Thermo Fisher Scientific Inc.\nâœ¦ Gedeon Richter\nâœ¦ Novartis\nâœ¦ Bayer HealthCare\nâœ¦ GlaxoSmithKline\nâœ¦ Hoffmann-La Roche Ltd\nâœ… Recent Developments:\nSeveral leading companies have expanded their global presence through mergers and acquisitions, bolstering their pipelines with assets targeting oncology, neurodegeneration, and rare genetic disorders.\nMajor firms have launched new collaborations with technology platforms, harnessing advancements in genomics and AI-driven drug discovery to accelerate clinical development and create more precise, effective therapies for refractory conditions.\nâœ… Conclusion\nThe innovative drugs market remains at the cusp of a healthcare revolution, powered by relentless R&D, patient-centric solutions, and unparalleled advances in biotechnology and data science. As found in persistence market research, the combination of robust pipeline activity, accelerated regulatory approvals, and rising disease awareness will ensure sustained growth and impact over the coming decades. With North America leading but Asia Pacific rapidly rising, and global companies continually seeking new science and market collaborations, the future promises innovative medicines that will both save and improve millions of lives worldwide.\nContact Us:\nPersistence Market Research\nG04 Golden Mile House, Clayponds Lane\nBrentford, London, TW8 0GU UK\nUSA Phone: +1 646-878-6329\nUK Phone: +44 203-837-5656\nEmail: sales@persistencemarketresearch.com\nWeb: https://www.persistencemarketresearch.com\nAbout Persistence Market Research:\nAt Persistence Market Research, we specialize in creating research studies that serve as strategic tools for driving business growth. Established as a proprietary firm in 2012, we have evolved into a registered company in England and Wales in 2023 under the name Persistence Research & Consultancy Services Ltd. With a solid foundation, we have completed over 3600 custom and syndicate market research projects, and delivered more than 2700 projects for other leading market research companies' clients.\nOur approach combines traditional market research methods with modern tools to offer comprehensive research solutions. With a decade of experience, we pride ourselves on deriving actionable insights from data to help businesses stay ahead of the competition. Our client base spans multinational corporations, leading consulting firms, investment funds, and government departments. A significant portion of our sales comes from repeat clients, a testament to the value and trust we've built over the years.\nThis release was published on openPR.",
    "highlightText": "",
    "highlightTitle": "",
    "highlightThreadTitle": "",
    "language": "english",
    "sentiment": "positive",
    "categories": [
      "Health",
      "Science and Technology",
      "Economy, Business and Finance"
    ],
    "topics": [
      "Health->health treatment and procedure",
      "Health->health organisation",
      "Health->drug rehabilitation",
      "Science and Technology->medical research",
      "Science and Technology->biotechnology",
      "Science and Technology->scientific research",
      "Economy, Business and Finance->healthcare industry",
      "Economy, Business and Finance->investment and opinion pieces",
      "Economy, Business and Finance->business strategy and marketing"
    ],
    "ai_allow": true,
    "has_canonical": false,
    "breaking": false,
    "webz_reporter": false,
    "external_links": [
      "https://opr.li/com/7b36f368c6a6fd8b83c28681749b01e6/",
      "https://www.persistencemarketresearch.com/request-customization/3311",
      "https://www.persistencemarketresearch.com",
      "https://opr.li/com/7426139f43127256a072eab5e52c250d/",
      "https://opr.li/com/ed1ed7f215757183a2bc201ae55e0f3f/",
      "https://www.persistencemarketresearch.com/samples/3311",
      "https://opr.li/com/05ee456dcf128f111a6c24637d890493/",
      "https://www.persistencemarketresearch.com/market-research/innovative-drugs-market.asp",
      "https://persistencemarketresearch.com/request-customization/3311",
      "https://www.opr.li/com/7b36f368c6a6fd8b83c28681749b01e6/",
      "https://persistencemarketresearch.com",
      "https://persistencemarketresearch.com/market-research/innovative-drugs-market.asp",
      "https://persistencemarketresearch.com/samples/3311",
      "https://www.opr.li/com/05ee456dcf128f111a6c24637d890493/",
      "https://www.opr.li/com/7426139f43127256a072eab5e52c250d/",
      "https://www.opr.li/com/ed1ed7f215757183a2bc201ae55e0f3f/",
      "https://opr.li/com/ed1ed7f215757183a2bc201ae55e0f3f",
      "https://opr.li/com/05ee456dcf128f111a6c24637d890493",
      "https://opr.li/com/7b36f368c6a6fd8b83c28681749b01e6",
      "https://opr.li/com/7426139f43127256a072eab5e52c250d"
    ],
    "external_images": [],
    "internal_images": [],
    "entities": {
      "persons": [],
      "locations": [],
      "organizations": []
    },
    "syndication": {
      "syndicated": false,
      "syndicate_id": null,
      "first_syndicated": false
    },
    "trust": {
      "categories": [],
      "top_news": [],
      "bias": null,
      "source": {
        "type": null,
        "city": null,
        "state": null,
        "country": null,
        "domain_type": null,
        "agency": null,
        "organization_name": null
      }
    },
    "rating": null,
    "crawled": "2025-07-31T07:35:32.684+03:00",
    "updated": "2025-07-31T07:40:02.000+03:00"
  },
  {
    "uuid": "5887353fec553f843c446e38c92d12e88d587edc",
    "url": "https://sportsnaut.com/new-york-mets-news-world-series-or-bust-year-one-juan-soto-era",
    "ord_in_thread": 0,
    "parent_url": null,
    "author": "Matt Higgins",
    "published": "2025-03-19T22:54:00Z",
    "title": "Facebook",
    "text": "The New York Mets are considered World Series favorites after shelling out a record-breaking $765 million contract for generational superstar Juan Soto .\nBeyond the Soto splash, they brought back homegrown All-Star Pete Alonso on a two-year deal, re-signed left-handed starter Sean Manaea , bolstered their pitching staff with Clay Holmes and Frankie Montas , and solidified their bullpen with A.J. Minter.\nThe Mets already boast one of the best lineups in the league. Along with Soto and Alonso, they feature 2024 MVP runner-up Francisco Lindor , Mark Vientos, and Brandon Nimmo. Francisco Alvarez, another key piece, will start the season on the injured list while recovering from a broken hamate bone in his left hand.\nAfter their surprise run to the NLCS where they were dispatched by the eventual World Series champion Los Angeles Dodgers , the Mets now have the fifth-best odds of winning the title themselves, according to DraftKings .\nWith such high expectations, is it World Series or bust for the Mets? A team analyst is sharing his perspective.\nNew York Mets analyst reveals 2025 win total In an interview with Sporstnautâ€™s â€œThe Deferralsâ€ baseball podcast , Mets On SI contributor and â€œMets Dailyâ€ host Jake Brown said the goal is the World Series, but the season wonâ€™t be a failure if they donâ€™t win a championship in Year One of the Soto Era.\nâ€œIs it World Series or bust? Not exactly. I think thatâ€™s the goal. I think thatâ€™s a realistic goal because, listen, if you could take down the Dodgers in a best of seven, thereâ€™s no question they could beat anyone from the American League,â€ stated Brown.\nBrown told â€œThe Deferralsâ€ that the Mets will need to stay healthy and add an arm to a rotation thatâ€™s already dealing with injuries to Montas and Manaea.\nâ€œIf they stay healthy and add someone to the rotation, I think they can compete for a title. I wonâ€™t call it World Series or bust. If they missed the playoffs, thatâ€™s a disgrace. I mean, thatâ€™s the bare minimum, where last year it was compete for the playoffs,â€ Brown added.\nâ€œThis year is, at least, get to the playoffs and then try to take down the Dodgers. Thatâ€™s the goal. Iâ€™m encouraged. I think at the minimum this is a 90-win team. If everything goes bad, 85 at the worst. But I think this team should win anywhere between 90 and 95 games.â€\nThe battle in the National League East promises to be fierce, with the Mets having to contend with powerhouse rivals in the Atlanta Braves and Philadelphia Phillies . According to DraftKings, the Braves and Phillies currently have the second- and fourth-best odds to win the World Series, respectively.\nThe Mets havenâ€™t been to the World Series since 2015, when they lost to the Kansas City Royals in five games.",
    "highlightText": "",
    "highlightTitle": "",
    "highlightThreadTitle": "",
    "language": "english",
    "sentiment": "positive",
    "categories": [
      "Sport",
      "Economy, Business and Finance"
    ],
    "topics": [
      "Sport->baseball",
      "Economy, Business and Finance->financial service",
      "Economy, Business and Finance->business strategy and marketing",
      "Economy, Business and Finance->tourism and leisure industry"
    ],
    "ai_allow": true,
    "has_canonical": false,
    "breaking": true,
    "webz_reporter": false,
    "external_links": [
      "http://www.youtube.com/watch?v=Uug31310JnY",
      "https://x.com/JakeBrownRadio",
      "https://sportsbook.draftkings.com/leagues/baseball/mlb?category=champion&subcategory=champion",
      "http://youtube.com/watch?v=Uug31310JnY",
      "http://www.youtube.com/watch",
      "https://www.x.com/JakeBrownRadio",
      "https://www.sportsbook.draftkings.com/leagues/baseball/mlb?category=champion&subcategory=champion",
      "https://sportsbook.draftkings.com/leagues/baseball/mlb"
    ],
    "external_images": [],
    "entities": {
      "persons": [],
      "locations": [],
      "organizations": []
    },
    "syndication": {
      "syndicated": false,
      "syndicate_id": null,
      "first_syndicated": false
    },
    "trust": null,
    "rating": null,
    "crawled": "2025-03-20T01:13:54.977+02:00",
    "updated": "2025-03-20T09:51:36.301+02:00"
  }
]